Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

455.48 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9

...

68 69 Next >

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today ↗

May 28, 2025

Via Benzinga

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow ↗

May 28, 2025

Via The Motley Fool

3 Top Growth Stocks to Buy in the Second Half of 2025 ↗

May 26, 2025

Via The Motley Fool

Topics Artificial Intelligence Government World Trade

2 Monster Growth Stocks to Buy and Hold for 10 Years ↗

May 24, 2025

Via The Motley Fool

Topics Bankruptcy

5 Health Care Stocks Whale Activity In Today's Session ↗

May 22, 2025

Via Benzinga

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 ↗

May 21, 2025

Via The Motley Fool

Topics Economy Law Enforcement

Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years ↗

May 20, 2025

Via Benzinga

CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy? ↗

May 20, 2025

Via The Motley Fool

VRTX Q1 Earnings Call: New Product Launches and Pipeline Progress Amid Revenue Miss

May 19, 2025

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 3% year on year to $2.77 billion. The company’s full-year revenue guidance of...

Via StockStory

Topics Intellectual Property

Warren Buffett Remains Optimistic About America. Here Are Top American Companies Worth Investing In. ↗

May 17, 2025

Via The Motley Fool

Topics Economy Government Supply Chain

1 Large-Cap Stock to Target This Week and 2 to Question

May 16, 2025

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for...

Via StockStory

Vertex to Participate in Upcoming Investor Conferences

May 15, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today ↗

May 13, 2025

Via Benzinga

Best Biotech Stocks to Buy in 2025

May 13, 2025

Discover the best biotech stocks of 2025, including top performers like Vertex and Regeneron, driven by clinical breakthroughs and strong investor momentum.

Via MarketBeat

Topics ETFs Economy Government

2 Biotech Stocks That Are Screaming Buys in May ↗

May 13, 2025

Via The Motley Fool

This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next ↗

May 13, 2025

Via The Motley Fool

S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform ↗

May 12, 2025

It's still unclear how President Donald Trump plans to tie drug prices in the U.S. to international prices.

Via Investor's Business Daily

Topics Government Stocks

Wynn Resorts, Microsoft, Palantir And A Health Care Stock On CNBC's 'Final Trades' ↗

May 12, 2025

Via Benzinga

Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years ↗

May 12, 2025

Via The Motley Fool

Eli Lilly, Affirm And Regeneron Are Among Top 12 Large-Cap Losers Last Week (May 5-May 9): Are The Others In Your Portfolio? ↗

May 11, 2025

The worst performing large-cap stocks last week: ARGENX, VRTX, SMMT, MMYT, REGN, RKT, BNTX, AFRM, FNF, LLY, AUR, DASH. Any in your portfolio?

Via Benzinga

My Favorite Tariff Safe-Haven Stock to Buy on the Dip ↗

May 10, 2025

Via The Motley Fool

Topics Government World Trade

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 09, 2025

Via Benzinga

4 No-Brainer Stocks to Buy Right Now ↗

May 09, 2025

Via The Motley Fool

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

May 08, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q1, starting with Vertex...

Via StockStory

Topics Artificial Intelligence

Top S&P500 movers in Wednesday's session ↗

May 07, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

What's going on in today's session: S&P500 movers ↗

May 07, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip ↗

May 07, 2025

Via The Motley Fool

Topics Earnings Intellectual Property Law Enforcement

Market Monitor May 7 ( Hims & Hers Health, Upwork UP - Palantir, Monderna DOWN) ↗

May 07, 2025

Markets slide on vaccine regulation fears, trade uncertainty, and cautious earnings despite strong tech and consumer stock moves.

Via Chartmill

1 S&P 500 Stock with Impressive Fundamentals and 2 to Ignore

May 07, 2025

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Via StockStory

Topics Stocks

Why Did Vertex Pharmaceuticals Stock Fall On Tuesday? ↗

May 06, 2025

Vertex posted Q1 EPS and sales below estimates but raised its 2025 revenue outlook, driven by CF drug demand and new product launches in the U.S.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.